Developer docs
API playgroundTry for free, no card

Search company profiles

Aspire Allergy & Sinus

Full company profile

uuid00062m5

Namestring
Aspire Allergy & Sinus
Legal namestring
Aspire Allergy & Sinus
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Aspire Allergy & Sinus is a privately-held, multi-state operator of outpatient allergy and sinus clinics, founded in 2012 in Austin, Texas, and structured as a management and support services provider to affiliated allergy practices. The company operates 50+ physical clinic locations across five states — Texas (the largest footprint), Arizona, Colorado, Florida, and New Mexico — delivering care on a direct-to-consumer basis through online scheduling and phone bookings (866-526-1499). Its service portfolio spans allergy testing for up to 58 environmental and food allergens, four immunotherapy modalities (subcutaneous shots, sublingual drops, oral immunotherapy / OIT, and the proprietary ExACT Immunoplasty℠ intralymphatic protocol), Xolair administration, and minimally invasive sinus procedures including balloon sinuplasty and deviated septum correction. Patient segments include adults and pediatric patients (4 months and older) with environmental allergies, food allergies, sinus conditions, and allergy-induced asthma.

The company's commercial model blends insurance-billed clinical services with a cash-pay proprietary procedure: ExACT Immunoplasty℠ is sold at $2,500 per three-injection treatment series (not covered by insurance, financed via CareCredit), generating high-margin per-patient revenue on top of recurring treatment-plan revenue from multi-year immunotherapy regimens. The differentiation rests on a trademarked intralymphatic immunotherapy technique developed through FDA-registered clinical trials with an 87.5% reported effectiveness rate and minimal reported pain, positioned against traditional weekly shots and daily medication. Growth is supported by digital-first patient acquisition (SEO blog, ACHOO! podcast, $100 referral program) and a workforce-pipeline partnership with Pulse Medical Assistant School (Zollege). Founder Allie Thompson remains CEO, leading a C-suite of COO Dustin Smith, CMO Goldyn Daupin, and CBO Shaun Miller; the company is privately held with Source Capital among historical investors.

Short descriptiontext

Aspire Allergy & Sinus operates 50+ outpatient allergy and sinus clinics across five U.S. states under a direct-to-consumer model, delivering allergy testing, multi-modality immunotherapy including the proprietary ExACT Immunoplasty℠, and minimally invasive sinus procedures to individuals with environmental, food, and sinus conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices49 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
allergy treatment services, sinus care clinics, immunotherapy treatments, allergy testing services, ENT specialty care
Industry3 codes
1Allergy & Immunology Clinics
CodeHLAKAAAAPrimaryYes
2Allergen Immunotherapy (SCIT/SLIT) Services
CodeHLAKAAAFPrimaryNo
3Rhinology & Sinus Surgery
CodeHLAKAMADPrimaryNo
NAICS code1 code
  • Offices of Physicians62111
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Allergy and Sinus Healthcare Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Services
TypeSubscription Recurring
Description

Revenue from patient office visits, allergy testing, and in-office procedures. Insurance billing for covered services including Medicare. Patient co-pays and deductibles apply.

einpresswire.com
2ExACT Immunoplasty (Cash Pay)
TypeOne Time License
Description

One-time cash pay procedure at $2,500 per treatment series. Not covered by insurance. Payment plans and financing options available through CareCredit.

aspireallergy.com
3Treatment Plans
TypeSubscription Recurring
Description

Ongoing treatment plans including allergy drops, shots, and oral immunotherapy with recurring office visits and periodic treatments.

aspireallergy.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1ExACT Immunoplasty - Single Treatment Series
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$2,500 total cost for 3 injections over 8 weeks. Does not include initial allergy test (insurance may apply). Payment plans offered.

aspireallergy.com
2Allergy Testing
ModelOtherBilling cadencePay-as-you-go
Notes

Insurance benefits may apply. Most health insurance companies do not pay for allergy testing until the annual deductible is met.

aspireallergy.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1ExACT Immunoplasty
Description

A form of allergy immunotherapy called intralymphatic immunotherapy that provides allergy relief in 8 weeks through 3 injections into the inguinal lymph node.

aspireallergy.com
Core offering1 text field

Aspire Allergy & Sinus operates a multi-state network of outpatient allergy and sinus clinics that deliver diagnostic testing (skin prick and blood tests covering up to 58 allergens) and a full suite of immunotherapy and sinus treatments, including allergy shots, sublingual allergy drops, oral immunotherapy (OIT), food allergy drops, the proprietary ExACT Immunoplasty intralymphatic immunotherapy, Xolair injections, and in-office sinus procedures such as Balloon Sinuplasty. Services are delivered directly to patients through a direct-to-consumer model with online and phone scheduling, and treatments are covered by insurance or paid in cash (e.g., ExACT at $2,500 per series).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 87.5% of patients see immediate results from ExACT Immunoplasty
+2 more records
Product overview1 text field

Aspire Allergy & Sinus operates a network of outpatient allergy and sinus clinics offering a comprehensive suite of diagnostic and therapeutic services. The portfolio spans allergy testing (environmental and food), three immunotherapy modalities — Allergy Drops (sublingual), Allergy Shots (subcutaneous), and the proprietary ExACT Immunoplasty℠ (intralymphatic) — plus Oral Immunotherapy (OIT) and Food Allergy Drops (Food SLIT) for food allergen desensitization, Xolair (omalizumab) injections, and in-office sinus procedures including Balloon Sinuplasty. The company positions itself as a one-stop specialty clinic providing complete, personalized allergy and sinus relief lasting years, rather than a technology product.

Product and service1 record
1Allergy Testing
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-12
Description

Pulse Medical Assistant School, operated by parent organization Zollege (founded 2010, operating 140+ campuses nationwide), launched a 16-week medical assistant program combining online instruction with hands-on clinical training at Aspire Allergy & Sinus clinics in Dallas.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AllerVie Health is the largest U.S. network of allergy, asthma, and immunology clinics, formed around Allergy Partners and several roll-ups, directly comparable to Aspire in service mix (immunotherapy, food allergy, sinus), clinic-operations model, and multi-state footprint.

TypeDirect peer
Description

Family Allergy & Asthma operates a multi-state network of specialty allergy, asthma and immunology clinics offering allergy testing, immunotherapy (shots/drops), and food allergy programs — directly mirroring Aspire's clinic-based, multi-modality treatment portfolio.

TypeDirect peer
Description

ENTA is a large Northeast-based physician group combining ENT and allergy services, including immunotherapy, balloon sinuplasty and chronic sinusitis care — a directly comparable clinical model that competes for the same patients seeking integrated ear-nose-throat and allergy treatment.

TypeDirect peer
Description

ADVENT is a multi-location sinus and ENT specialty clinic chain with a strong focus on in-office Balloon Sinuplasty and chronic sinusitis care, complementing allergy services — the same in-office sinus plus allergy positioning Aspire emphasizes in its value proposition.

TypeDirect peer
Description

Premier Allergy & Asthma Centers operates multi-provider allergy specialty clinics in the Midwest with immunotherapy, food allergy and sinus services — a smaller-scale but directly comparable clinic operator in the same specialty MSO lane as Aspire.

TypeDirect peer
Description

Texas ENT Specialists is a Texas-headquartered ENT and allergy physician group offering allergy testing, immunotherapy and sinus procedures — competing with Aspire for the same Texas-based patients and referring providers across overlapping service lines.

TypeDirect peer
Description

Charleston Allergy & Asthma is a regional specialty clinic group offering allergy testing, immunotherapy drops/shots, food allergy OIT and clinical research — a directly comparable multi-modality allergy practice serving a different U.S. geography.

TypeEmerging player
Description

Crossover Health operates modern, multi-site specialty and primary care clinics with employer-sponsored and consumer models, representing a broader emerging-specialty-clinic thesis that overlaps with how Aspire packages allergy and sinus services into accessible outpatient sites.

TypeBroad incumbent
Description

One Medical, now part of Amazon, is a national primary-care clinic network that offers allergy and immunology services within a much broader care portfolio — an incumbent that competes for the same consumer allergy patient via membership-based clinics and app-driven booking.

TypeBroad incumbent
Description

Teladoc Health provides nationwide telehealth visits for allergies, asthma and sinusitis, offering an at-home triage alternative for the patient segments (seasonal allergy sufferers, pediatric follow-ups) that Aspire also targets online and through in-clinic visits.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aspire Allergy & Sinus

Allergy and Sinus Healthcare Servicesaspireallergy.com

Aspire Allergy & Sinus operates 50+ outpatient allergy and sinus clinics across five U.S. states under a direct-to-consumer model, delivering allergy testing, multi-modality immunotherapy including the proprietary ExACT Immunoplasty℠, and minimally invasive sinus procedures to individuals with environmental, food, and sinus conditions.

What Aspire Allergy & Sinus does

Aspire Allergy & Sinus is a privately-held, multi-state operator of outpatient allergy and sinus clinics, founded in 2012 in Austin, Texas, and structured as a management and support services provider to affiliated allergy practices. The company operates 50+ physical clinic locations across five states — Texas (the largest footprint), Arizona, Colorado, Florida, and New Mexico — delivering care on a direct-to-consumer basis through online scheduling and phone bookings (866-526-1499). Its service portfolio spans allergy testing for up to 58 environmental and food allergens, four immunotherapy modalities (subcutaneous shots, sublingual drops, oral immunotherapy / OIT, and the proprietary ExACT Immunoplasty℠ intralymphatic protocol), Xolair administration, and minimally invasive sinus procedures including balloon sinuplasty and deviated septum correction. Patient segments include adults and pediatric patients (4 months and older) with environmental allergies, food allergies, sinus conditions, and allergy-induced asthma.

The company's commercial model blends insurance-billed clinical services with a cash-pay proprietary procedure: ExACT Immunoplasty℠ is sold at $2,500 per three-injection treatment series (not covered by insurance, financed via CareCredit), generating high-margin per-patient revenue on top of recurring treatment-plan revenue from multi-year immunotherapy regimens. The differentiation rests on a trademarked intralymphatic immunotherapy technique developed through FDA-registered clinical trials with an 87.5% reported effectiveness rate and minimal reported pain, positioned against traditional weekly shots and daily medication. Growth is supported by digital-first patient acquisition (SEO blog, ACHOO! podcast, $100 referral program) and a workforce-pipeline partnership with Pulse Medical Assistant School (Zollege). Founder Allie Thompson remains CEO, leading a C-suite of COO Dustin Smith, CMO Goldyn Daupin, and CBO Shaun Miller; the company is privately held with Source Capital among historical investors.

Aspire Allergy & Sinus firmographics

Firmographics
Name
Aspire Allergy & Sinus
Legal name
Aspire Allergy & Sinus
Website
https://aspireallergy.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Aspire Allergy & Sinus operates 50+ outpatient allergy and sinus clinics across five U.S. states under a direct-to-consumer model, delivering allergy testing, multi-modality immunotherapy including the proprietary ExACT Immunoplasty℠, and minimally invasive sinus procedures to individuals with environmental, food, and sinus conditions.
Ownership category
akta.pro rank

Aspire Allergy & Sinus industry classification

Industry
Product category
Allergy and Sinus Healthcare Services
NAICS
Offices of Physicians (62111)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Allergy & Immunology Clinics (HLAKAAAA)
akta.pro secondary industries
Allergen Immunotherapy (SCIT/SLIT) Services (HLAKAAAF), Rhinology & Sinus Surgery (HLAKAMAD)

Keywords

  • Allergy treatment services
  • Sinus care clinics
  • Immunotherapy treatments
  • Allergy testing services
  • ENT specialty care

Where Aspire Allergy & Sinus is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices49 records

Markets served

Aspire Allergy & Sinus business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Services: Revenue from patient office visits, allergy testing, and in-office procedures. Insurance billing for covered services including Medicare. Patient co-pays and deductibles apply.
  2. ExACT Immunoplasty (Cash Pay): One-time cash pay procedure at $2,500 per treatment series. Not covered by insurance. Payment plans and financing options available through CareCredit.
  3. Treatment Plans: Ongoing treatment plans including allergy drops, shots, and oral immunotherapy with recurring office visits and periodic treatments.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goExACT Immunoplasty - Single Treatment Series
OtherPay-as-you-goAllergy Testing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Aspire Allergy & Sinus product offering

Product offering

Core offering

Aspire Allergy & Sinus operates a multi-state network of outpatient allergy and sinus clinics that deliver diagnostic testing (skin prick and blood tests covering up to 58 allergens) and a full suite of immunotherapy and sinus treatments, including allergy shots, sublingual allergy drops, oral immunotherapy (OIT), food allergy drops, the proprietary ExACT Immunoplasty intralymphatic immunotherapy, Xolair injections, and in-office sinus procedures such as Balloon Sinuplasty. Services are delivered directly to patients through a direct-to-consumer model with online and phone scheduling, and treatments are covered by insurance or paid in cash (e.g., ExACT at $2,500 per series).

Product overview

Aspire Allergy & Sinus operates a network of outpatient allergy and sinus clinics offering a comprehensive suite of diagnostic and therapeutic services. The portfolio spans allergy testing (environmental and food), three immunotherapy modalities — Allergy Drops (sublingual), Allergy Shots (subcutaneous), and the proprietary ExACT Immunoplasty℠ (intralymphatic) — plus Oral Immunotherapy (OIT) and Food Allergy Drops (Food SLIT) for food allergen desensitization, Xolair (omalizumab) injections, and in-office sinus procedures including Balloon Sinuplasty. The company positions itself as a one-stop specialty clinic providing complete, personalized allergy and sinus relief lasting years, rather than a technology product.

Differentiator

Problem solved

Functional benefit

Brands

  • ExACT Immunoplasty: A form of allergy immunotherapy called intralymphatic immunotherapy that provides allergy relief in 8 weeks through 3 injections into the inguinal lymph node.

Products and services

  • Allergy Testing

Quantifiable outcome

  • 87.5% of patients see immediate results from ExACT Immunoplasty
  • +2 more outcomes

Companies that use Aspire Allergy & Sinus

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Aspire Allergy & Sinus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Aspire Allergy & Sinus partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pulse Medical Assistant School (Zollege)minorStrategic or Co-development Partner · 12 February 2026Pulse Medical Assistant School, operated by parent organization Zollege (founded 2010, operating 140+ campuses nationwide), launched a 16-week medical assistant program combining online instruction with hands-on clinical training at Aspire Allergy & Sinus clinics in Dallas.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Aspire Allergy & Sinus competitors and assessment

Company assessment

Direct peers

  • AllerVie Health (parent of Allergy Partners): AllerVie Health is the largest U.S. network of allergy, asthma, and immunology clinics, formed around Allergy Partners and several roll-ups, directly comparable to Aspire in service mix (immunotherapy, food allergy, sinus), clinic-operations model, and multi-state footprint.
  • Family Allergy & Asthma: Family Allergy & Asthma operates a multi-state network of specialty allergy, asthma and immunology clinics offering allergy testing, immunotherapy (shots/drops), and food allergy programs — directly mirroring Aspire's clinic-based, multi-modality treatment portfolio.
  • ENT and Allergy Associates (ENTA): ENTA is a large Northeast-based physician group combining ENT and allergy services, including immunotherapy, balloon sinuplasty and chronic sinusitis care — a directly comparable clinical model that competes for the same patients seeking integrated ear-nose-throat and allergy treatment.
  • ADVENT: ADVENT is a multi-location sinus and ENT specialty clinic chain with a strong focus on in-office Balloon Sinuplasty and chronic sinusitis care, complementing allergy services — the same in-office sinus plus allergy positioning Aspire emphasizes in its value proposition.
  • Premier Allergy & Asthma Centers: Premier Allergy & Asthma Centers operates multi-provider allergy specialty clinics in the Midwest with immunotherapy, food allergy and sinus services — a smaller-scale but directly comparable clinic operator in the same specialty MSO lane as Aspire.
  • Texas ENT Specialists: Texas ENT Specialists is a Texas-headquartered ENT and allergy physician group offering allergy testing, immunotherapy and sinus procedures — competing with Aspire for the same Texas-based patients and referring providers across overlapping service lines.
  • Charleston Allergy & Asthma: Charleston Allergy & Asthma is a regional specialty clinic group offering allergy testing, immunotherapy drops/shots, food allergy OIT and clinical research — a directly comparable multi-modality allergy practice serving a different U.S. geography.

Emerging players

  • Crossover Health: Crossover Health operates modern, multi-site specialty and primary care clinics with employer-sponsored and consumer models, representing a broader emerging-specialty-clinic thesis that overlaps with how Aspire packages allergy and sinus services into accessible outpatient sites.

Broad incumbents

  • One Medical (Amazon): One Medical, now part of Amazon, is a national primary-care clinic network that offers allergy and immunology services within a much broader care portfolio — an incumbent that competes for the same consumer allergy patient via membership-based clinics and app-driven booking.
  • Teladoc Health: Teladoc Health provides nationwide telehealth visits for allergies, asthma and sinusitis, offering an at-home triage alternative for the patient segments (seasonal allergy sufferers, pediatric follow-ups) that Aspire also targets online and through in-clinic visits.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aspire Allergy & Sinus social profiles

Digital presence

Aspire Allergy & Sinus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aspire Allergy & Sinus leadership team

Management profile

Number of profiles

Profiles9 records

Aspire Allergy & Sinus funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aspire Allergy & Sinus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspire Allergy & Sinus

What does Aspire Allergy & Sinus do?

Aspire Allergy & Sinus operates a multi-state network of outpatient allergy and sinus clinics that deliver diagnostic testing (skin prick and blood tests covering up to 58 allergens) and a full suite of immunotherapy and sinus treatments, including allergy shots, sublingual allergy drops, oral immunotherapy (OIT), food allergy drops, the proprietary ExACT Immunoplasty intralymphatic immunotherapy, Xolair injections, and in-office sinus procedures such as Balloon Sinuplasty. Services are delivered directly to patients through a direct-to-consumer model with online and phone scheduling, and treatments are covered by insurance or paid in cash (e.g., ExACT at $2,500 per series).

Is Aspire Allergy & Sinus a public or private company?

Aspire Allergy & Sinus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Aspire Allergy & Sinus founded?

Aspire Allergy & Sinus was founded in 2012. It employs 11 to 50 people.

Where is Aspire Allergy & Sinus based?

Aspire Allergy & Sinus is headquartered in Austin, United States, in the North America region.

How does Aspire Allergy & Sinus make money?

Three revenue lines are on record. Clinical Services are the primary driver. The others are exACT Immunoplasty (Cash Pay) and treatment Plans.

Who are Aspire Allergy & Sinus's main competitors?

Direct peers on record are AllerVie Health (parent of Allergy Partners), Family Allergy & Asthma, ENT and Allergy Associates (ENTA), ADVENT, Premier Allergy & Asthma Centers, Texas ENT Specialists and Charleston Allergy & Asthma. Crossover Health is listed as an emerging player. Broad incumbents are One Medical (Amazon) and Teladoc Health.

Does Aspire Allergy & Sinus have an API?

No public API is recorded for Aspire Allergy & Sinus.

What industry is Aspire Allergy & Sinus in?

Aspire Allergy & Sinus's product category is Allergy and Sinus Healthcare Services. Its primary akta.pro industry code is HLAKAAAA, Allergy & Immunology Clinics, with a secondary code of HLAKAAAF, Allergen Immunotherapy (SCIT/SLIT) Services. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswirePediatric Allergists Encourage Early Allergy Testing as Back-to-School Season BeginsPediatric allergists at Aspire Allergy & Sinus urge parents to seek early allergy testing as back-to-school season begins, noting symptoms like persistent sneezing and congestion may be allergies rather than colds. Untreated allergies can affect sleep, learning, and increase asthma risk through the Allergic March. Early diagnosis and treatment may improve quality of life and reduce disease progression.Community ImpactAspire Allergy & Sinus opens new location in GeorgetownAspire Allergy & Sinus opened a Georgetown location in early April, its eighth in the Greater Austin area. The Austin-based practice has over 60 locations across multiple states, offering allergy testing, treatment, and sinus care. The clinic will be led by physician assistant Kyle Bartschmid.EIN PresswireAustin Clinic Uses Accelerated Immunotherapy Approach to Reduce Allergy Treatment Time to Eight WeeksAspire Allergy & Sinus in Austin offers accelerated intralymphatic immunotherapy (ExACT Immunoplasty) that condenses allergy treatment into three injections over eight weeks. Since 2019, the clinic has treated 3,763 patients, with over 70% reporting meaningful improvement. The clinic cites lack of awareness as the main barrier to wider adoption.EIN PresswireAspire Allergy & Sinus Physician Highlights Promising Research on Needle-Free Treatment for Severe Allergic ReactionsAspire Allergy & Sinus allergist Dr. Haley Overstreet is highlighting new research on needle-free intranasal epinephrine treatment for severe allergic reactions, following publication of clinical data showing the approach may be highly effective in real-world settings. Intranasal epinephrine products such as neffy were recently approved in the United States as the first needle-free option for anaphylaxis management, potentially addressing one of the most common barriers to treatment: patient hesitation due to fear of needles. Allergy specialists say the new delivery method could help patients act faster during allergic reactions, reducing the risk of serious complications from delayed treatment.